Medicare Enrolled
Dr. Geetha Kamath, MD
Medical Oncology · St Petersburg, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kamath from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kamath? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kamath
Dr. Geetha Kamath is a medical oncology in St Petersburg, FL, with 20 years in practice. Based on federal Medicare data, Dr. Kamath performed 117,242 Medicare services across 1,825 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kamath received a total of $16,151 from 86 pharmaceutical and/or device companies across 750 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kamath is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 21% volume in FL$ $16,151 industry payments
Medicare Practice Summary
Medicare Utilization ↗117,242
Medicare services
Top 21% in FL for medical oncology
1,825
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,862 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 32,640 | $0 | $4 |
| Iron infusion (Injectafer) | 31,500 | $1 | $3 |
| Epoetin alfa injection (Procrit) for anemia | 18,680 | $6 | $23 |
| Denosumab injection (Prolia/Xgeva) | 12,960 | $18 | $51 |
| Anti-nausea injection (aprepitant) | 11,830 | $1 | $5 |
| Blood draw (venipuncture) | 1,705 | $8 | $9 |
| Dexamethasone injection (steroid) | 1,590 | $0 | $3 |
| Complete blood count (CBC) with differential | 1,565 | $8 | $29 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,030 | $1 | $28 |
| Office visit, established patient (30-39 min) | 713 | $93 | $339 |
| Drug injection, under skin or into muscle | 710 | $10 | $69 |
| Injection of additional new drug or substance into vein | 362 | $12 | $61 |
| Administration of chemotherapy into vein, 1 hour or less | 270 | $98 | $378 |
| Anti-nausea injection (ondansetron/Zofran) | 248 | $0 | $9 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 165 | $22 | $84 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 147 | $3 | $11 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 125 | $44 | $189 |
| Infusion, normal saline solution , 1000 cc | 114 | $2 | $7 |
| Infusion into a vein for hydration, 31-60 minutes | 109 | $24 | $156 |
| Injection, diphenhydramine hcl, up to 50 mg | 98 | $1 | $3 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 94 | $17 | $59 |
| Infusion into a vein for hydration, each additional hour | 80 | $10 | $42 |
| Administration of additional new drug or substance into vein, 1 hour or less | 63 | $49 | $178 |
| Injection of drug or substance into vein | 54 | $26 | $156 |
| Hospital follow-up visit, high complexity | 48 | $94 | $285 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 47 | $1 | $6 |
| New patient office visit, complex (60-74 min) | 46 | $157 | $585 |
| Office visit, established patient, complex (40-54 min) | 46 | $131 | $474 |
| Automated urinalysis | 44 | $2 | $8 |
| Red blood count, automated test | 39 | $4 | $10 |
| Office visit, established patient (20-29 min) | 35 | $60 | $239 |
| Initial hospital admission, high complexity | 23 | $137 | $556 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 18 | $11 | $56 |
| Hospital follow-up visit, moderate complexity | 17 | $63 | $197 |
| New patient office visit (45-59 min) | 15 | $116 | $453 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 12 | $135 | $467 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
55.2% high complexity
41.0% medium
3.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$16,151
Total received (2018-2024)
Avg $2,307/year across 7 years
Top 31% in FL for medical oncology
86
Companies
750
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,964 (86.5%)
Other
Charitable contributions, space rental, and other categories
$1,581 (9.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$605 (3.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,721
2023$3,537
2022$2,426
2021$108
2020$1,525
2019$2,619
2018$2,214
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$3,872
E.R. Squibb & Sons, L.L.C.
$969
Janssen Biotech, Inc.
$855
Daiichi Sankyo Inc.
$560
Merck Sharp & Dohme Corporation
$509
Lilly USA, LLC
$463
Amgen Inc.
$434
Astellas Pharma US Inc
$433
Celgene Corporation
$429
GENZYME CORPORATION
$385
AstraZeneca Pharmaceuticals LP
$380
PFIZER INC.
$379
Merck Sharp & Dohme LLC
$378
Genentech USA, Inc.
$377
Incyte Corporation
$373
NOVARTIS PHARMACEUTICALS CORPORATION
$321
Takeda Pharmaceuticals U.S.A., Inc.
$260
Gilead Sciences, Inc.
$256
Seattle Genetics, Inc.
$247
Seagen Inc.
$233
Regeneron Healthcare Solutions, Inc.
$210
Exelixis Inc.
$205
Boehringer Ingelheim Pharmaceuticals, Inc.
$190
JAZZ PHARMACEUTICALS INC.
$187
Eisai Inc.
$163
GlaxoSmithKline, LLC.
$154
Puma Biotechnology, Inc.
$154
ARRAY BIOPHARMA INC
$138
SOBI, INC
$125
EISAI INC.
$108
Kite Pharma, Inc.
$107
Blueprint Medicines Corporation
$105
Stemline Therapeutics Inc.
$103
Alexion Pharmaceuticals, Inc.
$102
PUMA BIOTECHNOLOGY, INC.
$97
TerSera Therapeutics LLC
$90
Pharmacosmos Therapeutics Inc.
$88
ABBVIE INC.
$85
Rigel Pharmaceuticals, Inc.
$79
G1 Therapeutics, Inc.
$75
TAIHO ONCOLOGY, INC.
$73
Sumitomo Pharma America, Inc.
$61
PharmaEssentia USA Corporation
$59
Mirati Therapeutics, Inc.
$56
Spectrum Pharmaceuticals Inc.
$53
AbbVie, Inc.
$51
EMD Serono, Inc.
$50
Janssen Pharmaceuticals, Inc
$49
Bayer HealthCare Pharmaceuticals Inc.
$48
Sysmex Inostics Inc
$46
BeiGene USA, Inc.
$44
EUSA Pharma (US) LLC
$41
Taiho Oncology, Inc.
$38
Karyopharm Therapeutics Inc.
$38
Sun Pharmaceutical Industries Inc.
$37
Sobi, Inc
$35
Tempus AI, Inc
$34
Helsinn Therapeutics (U.S.), Inc.
$34
SUN PHARMACEUTICAL INDUSTRIES INC.
$32
MEDIVATION FIELD SOLUTIONS LLC
$32
Agios Pharmaceuticals, Inc.
$31
Pharmacyclics LLC, an AbbVie Company
$31
Ipsen Biopharmaceuticals, Inc
$30
Adaptive Biotechnologies Corporation
$29
Legend Biotech USA Inc.
$29
Aurobindo Pharma USA, Inc.
$26
Clovis Oncology, Inc.
$25
SERVIER PHARMACEUTICALS LLC
$25
Fennec Pharmaceuticals, Inc.
$24
Alnylam Pharmaceuticals Inc.
$23
AVEO Pharmaceuticals, Inc.
$23
Partner Therapeutics, Inc.
$22
TESARO, Inc.
$21
GE HealthCare
$19
SANOFI-AVENTIS U.S. LLC
$19
Array BioPharma Inc.
$19
CTI BioPharma Corp.
$19
Fresenius Kabi USA, LLC
$19
Myriad Genetic Laboratories, Inc.
$19
Mylan Pharmaceuticals Inc.
$19
Lexicon Pharmaceuticals, Inc.
$18
Insmed, Inc.
$16
Deciphera Pharmaceuticals Inc.
$15
Kyowa Kirin, Inc.
$14
Myovant Sciences Inc.
$13
Acrotech Biopharma LLC
$13
Top 3 companies account for 35.3% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Arikayce · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABLIVI · CABOMETYX · CARVYKTI · CEREZYME · COSELA · CYRAMZA · Cabometyx · Cresemba · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · EMEND · ENHERTU · ENJAYMO · ERLEADA · Enhertu · FOTIVDA · FRUZAQLA · Fabhalta · Folotyn · Fulphila · GAUCHER-DISEASE · GAZYVA · GILOTRIF · HEMADY · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Inrebic · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Leukine · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · MYRISK · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · OJJAARA · ONPATTRO · OPDIVO · OPDUALAG · ORGOVYX · Odomzo · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · POLIVY · PROMACTA · Padcev · Pedmark · Perjeta · Pomalyst · QINLOCK · REBLOZYL · RYBREVANT · Rezlidhia · Rituxan Hycela · Rubraca · SANCUSO · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SUTENT · Somatuline Depot · Stimufend · Sylvant · TABRECTA · TAFINLAR · TAGRISSO · TASIGNA · TIBSOVO · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · VARUBI · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · Vonjo · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · Xermelo · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $14 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
64
Per 100K population
6.7
County median income
$70,293
Nearest hospital
HCA FLORIDA NORTHSIDE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kamath is a mixed practice specialist, with above-average Medicare volume (top 21% in FL), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kamath experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Kamath performed 32,640 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kamath receive payments from pharmaceutical companies?
Yes. Dr. Kamath received a total of $16,151 from 86 companies across 750 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kamath's costs compare to other medical oncologys in St Petersburg?
Dr. Kamath's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kamath) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in St Petersburg
Browse medical oncologys in St Petersburg ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in FL
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in FL
Which FL medical oncologys receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology